|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income | |||||
| Adjustments to net income: | |||||
| Depreciation | |||||
| Amortization of acquisition-related intangibles | |||||
| Amortization of capitalized software | |||||
| Stock compensation | |||||
| (Gains) losses on sales of assets | |||||
| Deferred taxes | |||||
| Increase (decrease) from changes in: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable and accrued expenses | |||||
| Accrued compensation | |||||
| Income taxes payable | |||||
| Changes in funded status of retirement plans | |||||
| Other | |||||
| Cash flows from operating activities | |||||
| Cash flows from investing activities | |||||
| Capital expenditures | |||||
| Proceeds from U.S. CHIPS and Science Act (CHIPS Act) incentives | |||||
| Total cash benefit related to the CHIPS Act | |||||
| Proceeds from asset sales | |||||
| Purchases of short-term investments | |||||
| Proceeds from short-term investments | |||||
| Other | |||||
| Cash flows from investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of long-term debt | |||||
| Repayment of debt | |||||
| Dividends paid | |||||
| Stock repurchases | |||||
| Proceeds from common stock transactions | |||||
| Other | |||||
| Cash flows from financing activities | |||||
| Net change in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
| Supplemental cash flow information | |||||
| Investment tax credit (ITC) used to reduce income taxes payable |
Loading...
